ABCA1 and glioblastoma: While ABCA1 and ABCD4 failed to denote a statistically significant result in the subsequent multivariate analysis, the fact that both were upregulated across multiple microarray datasets (6 datasets for the former, 4 datasets for the latter) advocates for closer scrutiny in future GBM therapy evaluations.